Skip to main content
Erschienen in: Tumor Biology 4/2015

01.04.2015 | Research Article

Genome-wide haplotype association study identifies BLM as a risk gene for prostate cancer in Chinese population

verfasst von: Qun Wang, Hongchao Lv, Wenhua Lv, Miao Shi, Mingming Zhang, Meiwei Luan, Hongjie Zhu, Ruijie Zhang, Yongshuai Jiang

Erschienen in: Tumor Biology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Prostate cancer (PC) is a common malignant tumor that occurs in the prostate epithelial cells. It is generally considered to be caused by both genetic and environmental factors. To identify the genetic risk factors of PC in Chinese population, we carried out a genome-wide haplotype-based association study. The 33 Chinese PC cases were from the public GEO database (GSE18333), and the 139 Chinese controls (CHB) were from the HapMap project. Our analysis included three stages: (1) identifying the linkage disequilibrium (LD) blocks and performing genome-wide haplotype association scan, (2) mapping PC-risk haplotypes to PC candidate genes, and (3) prioritizing PC candidate genes based on their similarity to known PC susceptibility genes. The results showed that (1) 749 haplotypes were significantly associated with PC (P < 1E−5). (2) Then, we mapped these significant haplotypes to genes and got 454 PC candidate genes. (3) After prioritizing the candidate genes based on their similarity to known PC susceptibility genes, we found that seven novel PC susceptibility genes including BLM, RPS6KA2, FRK, ERBB4, RBL1, PAK7, and ERBB2IP. Among the seven genes, BLM gene ranked first (P = 1.89E−04). A haplotype GGTTACCCCTC (rs2270131, rs2073919, rs11073953, rs12592875, rs16944863, rs2238337, rs414634, rs401549, rs17183344, rs16944884, and rs16944888) on chromosome 15q26.1 had significant association with PC (P = 2.37E−11). To our knowledge, this is the first genetic association study to show the significant association between BLM gene and PC susceptibility in Chinese population.
Literatur
1.
Zurück zum Zitat Kovac JR, Pan MM, Lipshultz LI, Lamb DJ. Current state of practice regarding testosterone supplementation therapy in men with prostate cancer. Steroids. 2014;89:27–32.CrossRefPubMed Kovac JR, Pan MM, Lipshultz LI, Lamb DJ. Current state of practice regarding testosterone supplementation therapy in men with prostate cancer. Steroids. 2014;89:27–32.CrossRefPubMed
3.
Zurück zum Zitat Ganju A, Yallapu MM, Khan S, Behrman SW, Chauhan SC, Jaggi M. Nanoways to overcome docetaxel resistance in prostate cancer. Drug Resist Updat. 2014;17:13–23.CrossRefPubMedPubMedCentral Ganju A, Yallapu MM, Khan S, Behrman SW, Chauhan SC, Jaggi M. Nanoways to overcome docetaxel resistance in prostate cancer. Drug Resist Updat. 2014;17:13–23.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Dinkel A, Kornmayer M, Gschwend JE, Marten-Mittag B, Herschbach P, Herkommer K. Influence of family history on psychosocial distress and perceived need for treatment in prostate cancer survivors. Familial Cancer. 2014;13:481–8.CrossRefPubMed Dinkel A, Kornmayer M, Gschwend JE, Marten-Mittag B, Herschbach P, Herkommer K. Influence of family history on psychosocial distress and perceived need for treatment in prostate cancer survivors. Familial Cancer. 2014;13:481–8.CrossRefPubMed
5.
Zurück zum Zitat Lee MM, Gomez SL, Chang JS, Wey M, Wang RT, Hsing AW. Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomark Prev : Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2003;12:665–8. Lee MM, Gomez SL, Chang JS, Wey M, Wang RT, Hsing AW. Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomark Prev : Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2003;12:665–8.
6.
Zurück zum Zitat Mao X, Yu Y, Boyd LK, Ren G, Lin D, Chaplin T, et al. Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis. Cancer Res. 2010;70:5207–12.CrossRefPubMedPubMedCentral Mao X, Yu Y, Boyd LK, Ren G, Lin D, Chaplin T, et al. Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis. Cancer Res. 2010;70:5207–12.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat International HapMap C. The international hapmap project. Nature. 2003;426:789–96.CrossRef International HapMap C. The international hapmap project. Nature. 2003;426:789–96.CrossRef
8.
Zurück zum Zitat Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, et al. A second generation human haplotype map of over 3.1 million snps. Nature. 2007;449:851–61.CrossRefPubMed Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, et al. A second generation human haplotype map of over 3.1 million snps. Nature. 2007;449:851–61.CrossRefPubMed
9.
Zurück zum Zitat Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, Schaffner SF, Yu F, et al. Integrating common and rare genetic variation in diverse human populations. Nature. 2010;467:52–8.CrossRefPubMed Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, Schaffner SF, Yu F, et al. Integrating common and rare genetic variation in diverse human populations. Nature. 2010;467:52–8.CrossRefPubMed
10.
Zurück zum Zitat Wang N, Akey JM, Zhang K, Chakraborty R, Jin L. Distribution of recombination crossovers and the origin of haplotype blocks: the interplay of population history, recombination, and mutation. Am J Hum Genet. 2002;71:1227–34.CrossRefPubMedPubMedCentral Wang N, Akey JM, Zhang K, Chakraborty R, Jin L. Distribution of recombination crossovers and the origin of haplotype blocks: the interplay of population history, recombination, and mutation. Am J Hum Genet. 2002;71:1227–34.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Barrett JC: Haploview: visualization and analysis of SNP genotype data. Cold Spring Harb Protoc 2009;2009:pdb ip71. Barrett JC: Haploview: visualization and analysis of SNP genotype data. Cold Spring Harb Protoc 2009;2009:pdb ip71.
12.
Zurück zum Zitat Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–5.CrossRefPubMed Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–5.CrossRefPubMed
13.
Zurück zum Zitat Aerts S, Lambrechts D, Maity S, Van Loo P, Coessens B, De Smet F, et al. Gene prioritization through genomic data fusion. Nat Biotechnol. 2006;24:537–44.CrossRefPubMed Aerts S, Lambrechts D, Maity S, Van Loo P, Coessens B, De Smet F, et al. Gene prioritization through genomic data fusion. Nat Biotechnol. 2006;24:537–44.CrossRefPubMed
14.
Zurück zum Zitat Tranchevent LC, Barriot R, Yu S, Van Vooren S, Van Loo P, Coessens B, et al. Endeavour update: a web resource for gene prioritization in multiple species. Nucleic Acids Res. 2008;36:W377–384.CrossRefPubMedPubMedCentral Tranchevent LC, Barriot R, Yu S, Van Vooren S, Van Loo P, Coessens B, et al. Endeavour update: a web resource for gene prioritization in multiple species. Nucleic Acids Res. 2008;36:W377–384.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Goodridge DM, Sloan JA, LeDoyen YM, McKenzie JA, Knight WE, Gayari M. Risk-assessment scores, prevention strategies, and the incidence of pressure ulcers among the elderly in four canadian health-care facilities. Can J Nurs Res = Revue Canadienne De Recherche En Sciences Infirmieres. 1998;30:23–44.PubMed Goodridge DM, Sloan JA, LeDoyen YM, McKenzie JA, Knight WE, Gayari M. Risk-assessment scores, prevention strategies, and the incidence of pressure ulcers among the elderly in four canadian health-care facilities. Can J Nurs Res = Revue Canadienne De Recherche En Sciences Infirmieres. 1998;30:23–44.PubMed
16.
Zurück zum Zitat Sassi A, Popielarski M, Synowiec E, Morawiec Z, Wozniak K. Blm and rad51 genes polymorphism and susceptibility to breast cancer. Pathol Oncol Res. 2013;19:451–9.CrossRefPubMedPubMedCentral Sassi A, Popielarski M, Synowiec E, Morawiec Z, Wozniak K. Blm and rad51 genes polymorphism and susceptibility to breast cancer. Pathol Oncol Res. 2013;19:451–9.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Sokolenko AP, Iyevleva AG, Preobrazhenskaya EV, Mitiushkina NV, Abysheva SN, Suspitsin EN, et al. High prevalence and breast cancer predisposing role of the blm c.1642 c > t (q548x) mutation in russia. Int J Cancer. 2012;130:2867–73.CrossRefPubMed Sokolenko AP, Iyevleva AG, Preobrazhenskaya EV, Mitiushkina NV, Abysheva SN, Suspitsin EN, et al. High prevalence and breast cancer predisposing role of the blm c.1642 c > t (q548x) mutation in russia. Int J Cancer. 2012;130:2867–73.CrossRefPubMed
18.
Zurück zum Zitat Bignone PA, Lee KY, Liu Y, Emilion G, Finch J, Soosay AE, et al. Rps6ka2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer. Oncogene. 2007;26:683–700.CrossRefPubMed Bignone PA, Lee KY, Liu Y, Emilion G, Finch J, Soosay AE, et al. Rps6ka2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer. Oncogene. 2007;26:683–700.CrossRefPubMed
19.
Zurück zum Zitat Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Herrick JS, Baumgartner KB, et al. Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population. Carcinogenesis. 2012;33:1512–21.CrossRefPubMedPubMedCentral Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Herrick JS, Baumgartner KB, et al. Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population. Carcinogenesis. 2012;33:1512–21.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Shi Q, Song X, Wang J, Gu J, Zhang W, Hu J, et al.: Frk inhibits migration and invasion of human glioma cells by promoting n-cadherin/beta-catenin complex formation. J Mol Neurosci 2014. Shi Q, Song X, Wang J, Gu J, Zhang W, Hu J, et al.: Frk inhibits migration and invasion of human glioma cells by promoting n-cadherin/beta-catenin complex formation. J Mol Neurosci 2014.
21.
Zurück zum Zitat Kurppa KJ, Rokavec M, Sundvall M, Kellokumpu-Lehtinen PL, Joensuu H, Brauch H, et al. Erbb4 promoter polymorphism is associated with poor distant disease-free survival in high-risk early breast cancer. PLoS One. 2014;9:e102388.CrossRefPubMedPubMedCentral Kurppa KJ, Rokavec M, Sundvall M, Kellokumpu-Lehtinen PL, Joensuu H, Brauch H, et al. Erbb4 promoter polymorphism is associated with poor distant disease-free survival in high-risk early breast cancer. PLoS One. 2014;9:e102388.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Barh D, Jain N, Tiwari S, Field JK, Padin-Iruegas E, Ruibal A, et al. A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer. BMC Genomics. 2013;14 Suppl 6:S5.CrossRefPubMedPubMedCentral Barh D, Jain N, Tiwari S, Field JK, Padin-Iruegas E, Ruibal A, et al. A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer. BMC Genomics. 2013;14 Suppl 6:S5.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Gu J, Li K, Li M, Wu X, Zhang L, Ding Q, et al. A role for p21-activated kinase 7 in the development of gastric cancer. FEBS J. 2013;280:46–55.CrossRefPubMed Gu J, Li K, Li M, Wu X, Zhang L, Ding Q, et al. A role for p21-activated kinase 7 in the development of gastric cancer. FEBS J. 2013;280:46–55.CrossRefPubMed
24.
Zurück zum Zitat Dai P, Xiong WC, Mei L. Erbin inhibits RAF activation by disrupting the Sur-8-Ras-Raf complex. J Biol Chem. 2006;281:927–33.CrossRefPubMed Dai P, Xiong WC, Mei L. Erbin inhibits RAF activation by disrupting the Sur-8-Ras-Raf complex. J Biol Chem. 2006;281:927–33.CrossRefPubMed
25.
Zurück zum Zitat Krstic M, Stajkovic N. [Risk for infection by lyme disease cause in green surfaces maintenance workers in Belgrade]. Vojnosanit Pregl Mil-Med Pharm Rev. 2007;64:313–8.CrossRef Krstic M, Stajkovic N. [Risk for infection by lyme disease cause in green surfaces maintenance workers in Belgrade]. Vojnosanit Pregl Mil-Med Pharm Rev. 2007;64:313–8.CrossRef
Metadaten
Titel
Genome-wide haplotype association study identifies BLM as a risk gene for prostate cancer in Chinese population
verfasst von
Qun Wang
Hongchao Lv
Wenhua Lv
Miao Shi
Mingming Zhang
Meiwei Luan
Hongjie Zhu
Ruijie Zhang
Yongshuai Jiang
Publikationsdatum
01.04.2015
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 4/2015
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2893-x

Weitere Artikel der Ausgabe 4/2015

Tumor Biology 4/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.